Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Hyperglycemia Global Clinical Trials Review, H1, 2014

Published: Apr-2014 | Format: PDF | GlobalData | Number of pages: 113 | Code: MRS - 24134


GlobalData's clinical trial report, "Hyperglycemia Global Clinical Trials Review, H1, 2014" provides data on the Hyperglycemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperglycemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperglycemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hyperglycemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hyperglycemia to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hyperglycemia to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hyperglycemia 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Hyperglycemia Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Hyperglycemia 33
Dec 06, 2011: Study Shows Combination Insulin Degludec/Insulin Aspart Significantly Reduced Hypoglycaemia In Type 1 And Type 2 Diabetes Patients 33
Nov 15, 2011: PhaseBio Announces Positive Results From Phase I/IIa Trial Of Glymera For Treatment Of Hyperglycemia In Patients With Type 2 Diabetes 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Sanofi 34
Clinical Trial Overview of Sanofi 34
Novo A/S 35
Clinical Trial Overview of Novo A/S 35
Eli Lilly and Company 36
Clinical Trial Overview of Eli Lilly and Company 36
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Children's Healthcare of Atlanta Inc. 38
Clinical Trial Overview of Children's Healthcare of Atlanta Inc. 38
AstraZeneca PLC 39
Clinical Trial Overview of AstraZeneca PLC 39
Vegenat, S.A. 40
Clinical Trial Overview of Vegenat, S.A. 40
Boehringer Ingelheim GmbH 41
Clinical Trial Overview of Boehringer Ingelheim GmbH 41
BIOGLANE, S.L.N.E. 42
Clinical Trial Overview of BIOGLANE, S.L.N.E. 42
Astellas Pharma Inc. 43
Clinical Trial Overview of Astellas Pharma Inc. 43
Clinical Trial Overview of Top Institutes / Government 44
Emory University 44
Clinical Trial Overview of Emory University 44
Karolinska Institutet 45
Clinical Trial Overview of Karolinska Institutet 45
Northwestern University 46
Clinical Trial Overview of Northwestern University 46
Kansas State University 47
Clinical Trial Overview of Kansas State University 47
University of Toronto 48
Clinical Trial Overview of University of Toronto 48
Mayo Clinic 49
Clinical Trial Overview of Mayo Clinic 49
U.S. Department of Veterans Affairs 50
Clinical Trial Overview of U.S. Department of Veterans Affairs 50
National Center for Research Resources 51
Clinical Trial Overview of National Center for Research Resources 51
Hadassah Medical Organization 52
Clinical Trial Overview of Hadassah Medical Organization 52
The Ohio State University 53
Clinical Trial Overview of The Ohio State University 53
Five Key Clinical Profiles 54
Appendix 111
Abbreviations 111
Definitions 111
Research Methodology 112
Secondary Research 112
About GlobalData 113
Contact Us 113
Disclaimer 113
Source 113

List of Tables

Hyperglycemia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Hyperglycemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hyperglycemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hyperglycemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Hyperglycemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Hyperglycemia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Hyperglycemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Hyperglycemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Hyperglycemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Hyperglycemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hyperglycemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hyperglycemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Hyperglycemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hyperglycemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hyperglycemia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Hyperglycemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Hyperglycemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hyperglycemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Hyperglycemia Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Hyperglycemia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Hyperglycemia Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Hyperglycemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Hyperglycemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Hyperglycemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Hyperglycemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Hyperglycemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 34
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2014* 35
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 36
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 37
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Healthcare of Atlanta Inc., 2014* 38
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 39
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Vegenat, S.A., 2014* 40
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2014* 41
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by BIOGLANE, S.L.N.E., 2014* 42
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 43
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 44
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institutet, 2014* 45
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 46
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kansas State University, 2014* 47
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2014* 48
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 49
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 50
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 51
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 52
Hyperglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2014* 53

List of Figures

Hyperglycemia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Hyperglycemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hyperglycemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hyperglycemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Hyperglycemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Hyperglycemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Hyperglycemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Hyperglycemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Hyperglycemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Hyperglycemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hyperglycemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hyperglycemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Hyperglycemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hyperglycemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hyperglycemia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Hyperglycemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Hyperglycemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hyperglycemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Hyperglycemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Hyperglycemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Hyperglycemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Hyperglycemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Hyperglycemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 112

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)2500 View Pricing